Ergoteles LLC Geron Corp Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $51,584 - $90,813	30,889 New	30,889 $72,000
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.65 $351,900 - $487,929	-295,715 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $208,383 - $336,780	210,488 Added 246.97%	295,715 $402,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $103,976 - $146,590	85,227 New	85,227 $104,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.